Duragesic-100 and Bactroban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duragesic-100 (fentanyl) and Bactroban (mupirocin). Common drug interactions include metastases to spine among females and retinal vascular thrombosis among males.

The phase IV clinical study analyzes what interactions people have when they take Duragesic-100 and Bactroban. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Duragesic-100?

Duragesic-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 19,509 Duragesic-100 users. Check the latest studies of Duragesic-100.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.

On Jul, 06, 2026

31 people who take Duragesic-100 and Bactroban together, and have interactions are studied.

Duragesic-100 and Bactroban drug interactions.

What are the common drug interactions of Duragesic-100 and Bactroban, by gender? *:

female:

Metastases to spine (cancer spreads to spine)
Spondylolisthesis (displacement of a vertebra or the vertebral column in relation to the vertebrae below)
Vertebral foraminal stenosis (narrowing of the intervertebral foramen)
Chest discomfort
Cough
Hyperhidrosis (abnormally increased sweating)
Influenza like illness
Oropharyngeal pain
Productive cough
Pyrexia (fever)

male:

Retinal vascular thrombosis (clot formation in small veins that carry blood away from the retina)
Anaemia (lack of blood)
Hepatomegaly (abnormal enlargement of the liver)
Injury
Interstitial lung disease
Intervertebral disc protrusion (spinal disc protrusion)
Lumbar radiculopathy (radicular pain in the low back and legs)
Nephrolithiasis (calculi in the kidneys)
Nerve root injury lumbar (nerve root injury at the lumber vertebra)
Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Duragesic-100 and Bactroban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Wound
Asthenia (weakness)
Confusional state
Constipation
Decreased appetite
Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
Depression
Fatigue (feeling of tiredness)
Gait disturbance
Hypercalcaemia (elevated calcium (ca+) level in the blood)

50-59:

Injury
Mass
Fatigue (feeling of tiredness)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Hypokalaemia (low potassium)
Lung neoplasm (tumour of lung)
Lymphadenopathy (disease or enlargement of lymph nodes)
Malaise (a feeling of general discomfort or uneasiness)
Metastases to bone (cancer spreads to bone)
Metastases to liver (cancer spreads to liver)

60+:

Retinal vascular thrombosis (clot formation in small veins that carry blood away from the retina)
Retinal vascular disorder (a range of eye diseases that affect the blood vessels in the eye)
Arthralgia (joint pain)
Vision blurred
Pulmonary oedema (fluid accumulation in the lungs)

What are the existing conditions these people have? *

Resorption Bone Increased: 10 people, 32.26%
Neck Pain: 6 people, 19.35%
Cough: 6 people, 19.35%
Stomatitis (inflammation of mucous membrane of mouth): 5 people, 16.13%
Nausea And Vomiting: 5 people, 16.13%
Mydriasis (a dilation of the pupil): 5 people, 16.13%
Joint Pain: 5 people, 16.13%
High Blood Pressure: 5 people, 16.13%
Hepatitis B: 5 people, 16.13%
Hepatic Neoplasm Malignant (liver cancer): 5 people, 16.13%

* Approximation only. Some reports may have incomplete information.

Do you take Duragesic-100 and Bactroban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously